| 1. | dwright29 | |
| 2. | servigener | |
| 3. | MAJDAVARAN | |
| 4. | golemelin | |
| 5. | lucaptr |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | golemelin 02/09/2018 Presents preliminary Phase 1 data on Tislelizumab in patients with Urothelial Carcinoma |
| 2. | dwright29 02/05/2018 Announced the commercial availability of VIDAZA (azacitidine for injection) in China |
| 3. | golemelin 01/31/2018 Great pipeline with this bio |
| 4. | MAJDAVARAN 09/27/2017 Bios are doing a lot better lately |
| 5. | servigener 01/31/2018 More DD |
| 6. | dwright29 02/12/2018 BeiGene Presents Preliminary Phase 1 Data on Tislelizumab in Patients with Urothelial Carcinoma at 2018 Genitourinary Cancers Symposium |
| 7. | servigener 01/31/2018 Good hopes with $BGNE |
| 8. | MAJDAVARAN 01/18/2018 Market really liked this>?! |
| 9. | lucaptr 02/07/2018 If you trust Maxim |
| 10. | dwright29 01/18/2018 BeiGene Announces Pricing of $750 Million Public Offering |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
BeiGene, Ltd.
- BGNE
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.